Viewing nowMontelukast Chewable Tablets 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

MFDS item code 201901655 · Approved 2019.03.19 · Insurance code 670501450
Relief of allergic rhinitis symptoms; prevention and maintenance treatment of asthma
This medication helps prevent and treat asthma on an ongoing basis. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis. Thus, it is effective in managing respiratory-related allergic diseases.
Take this drug once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. To take, pour 1 sachet of this drug into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this drug standing in water as a suspension for a prolonged period.
Children aged 6~14 years: Chew and take 5 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew and take 4 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months to under 2 years: Administer 4 mg of this drug orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months to under 2 years: Administer 4mg of this drug orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age. The 4 mg granules of this drug may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as baby food, breast milk, or porridge, at room temperature or cooler. Do not open the package until immediately before use. After opening, mix with baby food, breast milk, or food, or take the entire contents directly, immediately (within 15 minutes). Do not leave this drug mixed with baby food, breast milk, or food for a prolonged period; discard any remaining amount. This formulation is not intended to be mixed with beverages other than baby food or breast milk, but a beverage may be taken immediately after administration. This drug may be taken without regard to mealtimes.
This medication is used for the treatment of asthma and allergic rhinitis. During the use of this medication, abnormalities in the neuropsychiatric system may occur, so if symptoms such as agitation, aggressive behavior, anxiety, depression, hallucinations, or suicidal thoughts appear, immediate consultation with a doctor is necessary. This medication contains aspartame, an artificial sweetener, so patients with phenylketonuria should avoid use. If the formulation contains lactose, patients with genetic issues such as galactose intolerance or lactase deficiency should not take it. This medication is not for use during an acute asthma attack; a rescue inhaler should be kept and used in the presence of acute symptoms. Do not use alone for the treatment of exercise-induced bronchospasm; other inhalers should be used as needed. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not use these medications while taking this drug. During treatment, abnormalities in liver function, skin rashes, gastrointestinal symptoms, respiratory symptoms, and other adverse effects may occur; any unusual symptoms should be reported to a doctor. Pregnant or breastfeeding women should take this medication only when necessary and after consulting a doctor. Children and the elderly can also use it, but dosage and precautions may vary by age, and physician instructions should be followed. In case of overdose, as there are no specific antidotes, one should visit a medical facility immediately to receive appropriate treatment. Keep this medication out of reach of children and do not transfer it to other containers. During treatment, if asthma symptoms worsen or if the use of rescue inhalers becomes more frequent than usual, consult a doctor. Any newly developed or worsened neuropsychiatric symptoms during treatment should be immediately reported to healthcare personnel, and discontinuation may be directed by a doctor.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air, moisture, and light. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the effectiveness and safety of the medication.
Pink chewable tablet with a biconvex round shape
28 tablets (7 tablets/PTP X 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.